The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

PDL BioPharma Completes Regular Quarterly Dividend Payment

Tuesday, March 12, 2013

PDL BioPharma Completes Regular Quarterly Dividend Payment16:02 EDT Tuesday, March 12, 2013INCLINE VILLAGE, Nev., March 12, 2013 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that it has paid the March 12, 2013, regular quarterly dividend payment of $0.15 per share to all stockholders owning shares of PDL as of March 5, 2013, the record date. (Logo: About PDL BioPharmaPDL pioneered the humanization of monoclonal antibodies and, by doing so, enabled the discovery of a new generation of targeted treatments for cancer and immunologic diseases. Today, PDL is focused on intellectual property asset management, investing in new income generating assets and maximizing value for its shareholders. For more information, please visit  NOTE: PDL BioPharma and the PDL BioPharma logo are considered trademarks of PDL BioPharma, Inc.SOURCE PDL BioPharma, Inc.For further information: John P. McLaughlin, PDL BioPharma, Inc., 775-832-8500,, or Jennifer Williams, Cook Williams Communications, Inc., 360-668-3701,